The best-selling drugs of the next 5 years - Pharma Excipients
$ 15.99 · 5 (745) · In stock
Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual revenue in 2023, earning $22.2 billion
Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual revenue in 2023, earning $22.2 billion by 2025, according to new research by GlobalData.Article by pharmaphorum.comThe data forecasts th
The top 20 drugs by 2021 sales
World's Top Selling Pharmaceutical Drugs and Manufacturers by Sales
50 of 2021's best-selling pharmaceuticals
Top drugs and companies by sales in 2017
Biggest blockbuster drugs of 2020 : Drug sales and beyond – Pharmaceutical Marketing and Strategies for Today
New Drug Modalities 2023
Top 10 Most Anticipated Drug Launches Of 2024
Biggest blockbuster drugs of 2020 : Drug sales and beyond – Pharmaceutical Marketing and Strategies for Today
Top 10 most anticipated drug launches of 2023